Kohichiro Shigeno

The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms

W Zhang, Kazunori Ohnishi, Kohichiro Shigeno et al. · Leukemia · 1998 · 160 citations

Cell Division, Medicine, Apoptosis +7

Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines

Kensuke Naito, Akihiro Takeshita, Kohichiro Shigeno et al. · Leukemia · 2000 · 152 citations

Hematological Malignancy, Cytocidal Effect, P-glycoprotein-expressing Sublines +10

Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia

J-M Luo, Hitomi Yoshida, Sadaaki KOMURA et al. · Leukemia · 2003 · 125 citations

Hematological Malignancy, Chromatin, Genetic Disorder +10

Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers

Hirotaka Matsui, Akihiro Takeshita, Kensuke Naito et al. · Leukemia · 2002 · 104 citations

Hematological Malignancy, Gemtuzumab Ozogamicin, Health Sciences +10

The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia

Sayaka Nakamura, Isao Hirano, Keiji Okinaka et al. · Carcinogenesis · 2010 · 104 citations · Full text

Leukemia Cells, Cell Proliferation, Cancer Biology +17